Thienopyridine
|
WikiDoc Resources for Thienopyridine |
|
Articles |
|---|
|
Most recent articles on Thienopyridine Most cited articles on Thienopyridine |
|
Media |
|
Powerpoint slides on Thienopyridine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Thienopyridine at Clinical Trials.gov Trial results on Thienopyridine Clinical Trials on Thienopyridine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Thienopyridine NICE Guidance on Thienopyridine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Thienopyridine Discussion groups on Thienopyridine Patient Handouts on Thienopyridine Directions to Hospitals Treating Thienopyridine Risk calculators and risk factors for Thienopyridine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Thienopyridine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Thienopyridines are a class of ADP receptor/P2Y12 inhibitors used for their anti-platelet activity.
Examples
These drugs include:
Prasugrel,[1] Ticlopidine (Ticlid), Clopidogrel (Plavix).
References
- ↑ Angiolillo DJ, Bates ER, Bass TA (2008). "Clinical profile of prasugrel, a novel thienopyridine". Am. Heart J. 156 (2 Suppl): S16–22. doi:10.1016/j.ahj.2008.06.005. PMID 18657682. Unknown parameter
|month=ignored (help)